Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Loxo Oncology Inc (NASDAQ:LOXO)

86.74
BATS BZX Real-Time Price
As of 12:42pm ET
 +1.71 / +2.01%
Today’s Change
17.14
Today|||52-Week Range
95.92
+170.09%
Year-to-Date
No recent news for Loxo Oncology Inc.

Today’s Trading

Previous close85.03
Today’s open86.61
Day’s range85.75 - 87.30
Volume3,077
Average volume (3 months)407,633
Market cap$2.5B
Dividend yield--
Data as of 12:42pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-63.21%
Earnings growth (this year)-27.74%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book14.16

Competitors

 Today’s
change
Today’s
% change
RAREUltragenyx Pharmaceu...-0.84-1.64%
SRPTSarepta Therapeutics...+0.56+1.10%
IRWDIronwood Pharmaceuti...-0.10-0.67%
PRTAProthena Corporation...+0.06+0.10%
Data as of 12:41pm ET, 10/20/2017

Financials

Next reporting dateNovember 16, 2017
EPS forecast (this quarter)-$1.23
Annual revenue (last year)$0.00
Annual profit (last year)-$72.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Josh Bilenker
Executive Director-
Business Operations
Sara Slifka
Corporate headquarters
Stamford, Connecticut

Forecasts